Conclusion: The research shows that hepatobiliary contrast agents increases the diagnostic accuracy of MRI hepatocellular carcinoma in cirrhotic patients, small metastases, differentiation between focal nodular hyperplasia and adenoma, hemangiomas, dysplastic nodule and early-stage hepatocellular carcinoma.